Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study - Danese, S; Colombel, JF; Lukas, M (Lancet Gastroenterol Hepatol, 2022)
et al.